Figures & data
Table 1 Studies of rifaximin in patients with IBS
Figure 1 Percentage of patients with relief of symptoms during the primary evaluation period (weeks 3–6).
Note: Rifaximin 550 mg or placebo three times daily.
Abbreviation: IBS, irritable bowel syndrome.
Abbreviation: IBS, irritable bowel syndrome.
![Figure 1 Percentage of patients with relief of symptoms during the primary evaluation period (weeks 3–6).](/cms/asset/63bc3b3a-d55f-4c27-9a99-6a43e6d59462/dceg_a_67231_f0001_b.jpg)